世界の眼科疾患治療薬市場は、2021年に約315億4,000万米ドルとなり、予測期間の2022年から2029年には6.4%以上の健全な成長率で成長すると予測されています。緑内障、ドライアイ、網膜疾患など、様々な眼疾患を治療するための薬剤や治療薬は、眼科疾患治療薬に含まれます。眼科疾患治療薬市場は、眼科疾患の有病率の上昇、革新的な医薬品や治療薬の臨床試験やパイプライン候補の増加などの要因で拡大しています。
世界的には、緑内障、網膜疾患、ドライアイ疾患などの眼科疾患の有病率が増加しており、市場の成長に応えています。米国眼科学会（AAO）の2020年の論文によると、300万人のアメリカ人（そのうち270万人が40歳以上）が緑内障を患っています。世界銀行グループによると、2020年の世界の高齢者人口は7億2,700万人で、今後30年間で3倍に増加し、2050年には15億人に達すると予測されています。様々な医療機関、政府機関、業界関係者による取り組みの増加、眼疾患に対する国民の意識の高まり、医療費の増加、先進国・発展途上国の眼科医数の増加などの要因により、眼疾患の治療に対する市場需要は増加すると予想されます。ウェールズ政府の2021年報告書によると、ウェールズの眼科開業医の数は2020年3月の885人から2021年3月には961人に上昇した。しかし、眼科疾患治療薬の高コストが、2022年から2029年の予測期間を通じて市場の成長を阻害しています。
眼科疾患治療薬の世界市場の調査対象地域は、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他の地域です。北アメリカは、診断と治療の割合の増加、および多くの眼疾患の有病率の増加により、収益面で市場を支配しています。さらに、この地域では、アイケアや目の健康を支援する医療費が増加しており、さまざまな眼科疾患に対する補償が認められていることから、この地域の主要国では、最先端かつ新規の治療法の導入が進んでいます。一方、ヨーロッパは、老人人口の増加、製品開発のための共同研究の増加、主要企業の地域的拡大、政府および非営利団体の市場参入などの要因により、予測期間中に最も高いCAGRで成長すると予測されます。
本調査の目的は、近年における様々なセグメント・国の市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。
さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。
目次
Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Ophthalmic Disease Therapeutics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Ophthalmic Disease Therapeutics Market, by Drug Class, 2019-2029 (USD Billion)
1.2.3. Ophthalmic Disease Therapeutics Market, by Dosage From, 2019-2029 (USD Billion)
1.2.4. Ophthalmic Disease Therapeutics Market, by Disease Indication, 2019-2029 (USD Billion)
1.2.5. Ophthalmic Disease Therapeutics Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Ophthalmic Disease Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Ophthalmic Disease Therapeutics Market Dynamics
3.1. Ophthalmic Disease Therapeutics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising Prevalence of Ophthalmic Conditions
3.1.1.2. Increasing Clinical Trials and Pipeline Candidates for Innovative Drugs and Therapies
3.1.2. Market Challenges
3.1.2.1. High Cost of Biologics and Overall Treatment Cost
3.1.3. Market Opportunities
3.1.3.1. Rising Technological Advancements in Drug Delivery Options
3.1.3.2. Rising development of personalised medicine
Chapter 4. Global Ophthalmic Disease Therapeutics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Ophthalmic Disease Therapeutics Market, by Drug Class
6.1. Market Snapshot
6.2. Global Ophthalmic Disease Therapeutics Market by Drug Class, Performance - Potential Analysis
6.3. Global Ophthalmic Disease Therapeutics Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
6.4. Ophthalmic Disease Therapeutics Market, Sub Segment Analysis
6.4.1. Anti-inflammatory
6.4.2. Anti-invectives
6.4.3. Anti-VEGF
6.4.4. Others
Chapter 7. Global Ophthalmic Disease Therapeutics Market, by Dosage From
7.1. Market Snapshot
7.2. Global Ophthalmic Disease Therapeutics Market by Dosage From, Performance - Potential Analysis
7.3. Global Ophthalmic Disease Therapeutics Market Estimates & Forecasts by Dosage From 2019-2029 (USD Billion)
7.4. Ophthalmic Disease Therapeutics Market, Sub Segment Analysis
7.4.1. Solid
7.4.2. Liquid
7.4.3. Semisolid
Chapter 8. Global Ophthalmic Disease Therapeutics Market, by Disease Indication
8.1. Market Snapshot
8.2. Global Ophthalmic Disease Therapeutics Market by Disease Indication, Performance - Potential Analysis
8.3. Global Ophthalmic Disease Therapeutics Market Estimates & Forecasts by Disease Indication 2019-2029 (USD Billion)
8.4. Ophthalmic Disease Therapeutics Market, Sub Segment Analysis
8.4.1. Glaucoma
8.4.2. Dry Eye Disease
8.4.3. Retinal Disease
8.4.4. Allergy & Infections
8.4.5. Others
Chapter 9. Global Ophthalmic Disease Therapeutics Market, by Distribution Channel
9.1. Market Snapshot
9.2. Global Ophthalmic Disease Therapeutics Market by Distribution Channel, Performance - Potential Analysis
9.3. Global Ophthalmic Disease Therapeutics Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
9.4. Ophthalmic Disease Therapeutics Market, Sub Segment Analysis
9.4.1. Hospital Pharmacies
9.4.2. Retail & Online Pharmacies
Chapter 10. Global Ophthalmic Disease Therapeutics Market, Regional Analysis
10.1. Ophthalmic Disease Therapeutics Market, Regional Market Snapshot
10.2. North America Ophthalmic Disease Therapeutics Market
10.2.1. U.S. Ophthalmic Disease Therapeutics Market
10.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
10.2.1.2. Dosage From breakdown estimates & forecasts, 2019-2029
10.2.1.3. Disease Indication breakdown estimates & forecasts, 2019-2029
10.2.1.4. Distribution Channel breakdown estimates & forecasts, 2019-2029
10.2.2. Canada Ophthalmic Disease Therapeutics Market
10.3. Europe Ophthalmic Disease Therapeutics Market Snapshot
10.3.1. U.K. Ophthalmic Disease Therapeutics Market
10.3.2. Germany Ophthalmic Disease Therapeutics Market
10.3.3. France Ophthalmic Disease Therapeutics Market
10.3.4. Spain Ophthalmic Disease Therapeutics Market
10.3.5. Italy Ophthalmic Disease Therapeutics Market
10.3.6. Rest of Europe Ophthalmic Disease Therapeutics Market
10.4. Asia-Pacific Ophthalmic Disease Therapeutics Market Snapshot
10.4.1. China Ophthalmic Disease Therapeutics Market
10.4.2. India Ophthalmic Disease Therapeutics Market
10.4.3. Japan Ophthalmic Disease Therapeutics Market
10.4.4. Australia Ophthalmic Disease Therapeutics Market
10.4.5. South Korea Ophthalmic Disease Therapeutics Market
10.4.6. Rest of Asia Pacific Ophthalmic Disease Therapeutics Market
10.5. Latin America Ophthalmic Disease Therapeutics Market Snapshot
10.5.1. Brazil Ophthalmic Disease Therapeutics Market
10.5.2. Mexico Ophthalmic Disease Therapeutics Market
10.5.3. Rest of Latin America Ophthalmic Disease Therapeutics Market
10.6. Rest of The World Ophthalmic Disease Therapeutics Market
Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Viatris Inc.
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Novartis AG
11.2.3. AbbVie Inc.
11.2.4. F. Hoffmann-La Roche Ltd.
11.2.5. Regeneron Pharmaceuticals, Inc.
11.2.6. Santen Pharmaceutical Co., Ltd.
11.2.7. Bayer AG
11.2.8. Bausch & Lomb Incorporated
11.2.9. Merck KGaA
11.2.10. Nicox SA
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
List of Tables
TABLE 1. Global Ophthalmic Disease Therapeutics Market, report scope
TABLE 2. Global Ophthalmic Disease Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Ophthalmic Disease Therapeutics Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
TABLE 4. Global Ophthalmic Disease Therapeutics Market estimates & forecasts by Dosage From 2019-2029 (USD Billion)
TABLE 5. Global Ophthalmic Disease Therapeutics Market estimates & forecasts by Disease Indication 2019-2029 (USD Billion)
TABLE 6. Global Ophthalmic Disease Therapeutics Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
TABLE 7. Global Ophthalmic Disease Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Ophthalmic Disease Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Ophthalmic Disease Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Ophthalmic Disease Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Ophthalmic Disease Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Ophthalmic Disease Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Ophthalmic Disease Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Ophthalmic Disease Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Ophthalmic Disease Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. Global Ophthalmic Disease Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 18. U.S. Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. U.S. Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 21. Canada Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. Canada Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 24. UK Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. UK Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 27. Germany Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. Germany Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 30. France Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. France Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 33. Italy Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Italy Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 36. Spain Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. Spain Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 39. RoE Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. RoE Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 42. China Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. China Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 45. India Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. India Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 48. Japan Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. Japan Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 51. South Korea Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. South Korea Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 54. Australia Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. Australia Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 57. RoAPAC Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. RoAPAC Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 60. Brazil Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Brazil Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 63. Mexico Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. Mexico Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 66. RoLA Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. RoLA Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Ophthalmic Disease Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 69. Row Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. Row Ophthalmic Disease Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 71. List of secondary sources, used in the study of global Ophthalmic Disease Therapeutics Market
TABLE 72. List of primary sources, used in the study of global Ophthalmic Disease Therapeutics Market
TABLE 73. Years considered for the study
TABLE 74. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
FIG 1. Global Ophthalmic Disease Therapeutics Market, research methodology
FIG 2. Global Ophthalmic Disease Therapeutics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Ophthalmic Disease Therapeutics Market, key trends 2021
FIG 5. Global Ophthalmic Disease Therapeutics Market, growth prospects 2022-2029
FIG 6. Global Ophthalmic Disease Therapeutics Market, porters 5 force model
FIG 7. Global Ophthalmic Disease Therapeutics Market, pest analysis
FIG 8. Global Ophthalmic Disease Therapeutics Market, value chain analysis
FIG 9. Global Ophthalmic Disease Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Ophthalmic Disease Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Ophthalmic Disease Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Ophthalmic Disease Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Ophthalmic Disease Therapeutics Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Ophthalmic Disease Therapeutics Market, regional snapshot 2019 & 2029
FIG 15. North America Ophthalmic Disease Therapeutics Market 2019 & 2029 (USD Billion)
FIG 16. Europe Ophthalmic Disease Therapeutics Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Ophthalmic Disease Therapeutics Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Ophthalmic Disease Therapeutics Market 2019 & 2029 (USD Billion)
FIG 19. Global Ophthalmic Disease Therapeutics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
